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ABSTRACT
Chromatin structure and its alteration play critical
roles in the regulation of transcription. However, the
transcriptional silencing mechanism with regard to
the chromatin structure at an unstimulated state of
the interferon (IFN)-stimulated gene (ISG) remains
unclear. Here we investigated the role of template ac-
tivating factor-I (TAF-I, also known as SET) in ISG
transcription. Knockdown (KD) of TAF-I increased
ISG transcript and simultaneously reduced the his-
tone H1 level on the ISG promoters during the early
stages of transcription after IFN stimulation from the
unstimulated state. The transcription factor levels on
the ISG promoters were increased in TAF-I KD cells
only during the early stages of transcription. Further-
more, histone H1 KD also increased ISG transcript.
TAF-I and histone H1 double KD did not show the
additive effect in ISG transcription, suggesting that
TAF-I and histone H1 may act on the same regula-
tory pathway to control ISG transcription. In addition,
TAF-I KD and histone H1 KD affected the chromatin
structure near the ISG promoters. On the basis of
these findings, we propose that TAF-I and its target
histone H1 are key regulators of the chromatin struc-
ture at the ISG promoter to maintain the silent state
of ISG transcription.
INTRODUCTION
Transcriptional regulation is accomplished mainly by the
regulatory elements such as promoters and enhancers, those
of which have a variety of binding sites for sequence-specific
transcription factors, and specify characteristic chromatin
structuresmediated by nucleosome positioning, specific his-
tone modifications, histone variants and other factors (1,2).
For the transcription of type-I interferon (IFN)-stimulated
genes (ISGs), ISG promoters containing sequence motifs,
known as IFN-stimulated response element (ISRE), are the
binding sites of the sequence-specific transcription factors
activated by IFN stimulation. The chromatin structure and
histone modification around ISRE are regulated by coacti-
vators for ISG transcription (3,4).
IFN, in particular type-I IFN, plays a critical role in cellu-
lar antiviral mechanisms by inducing immediate transcrip-
tion of ISGs, which encode proteins that not only have anti-
viral activities but also affect host-cellular events, such as
cell death,messenger ribonucleic acid (mRNA) degradation
and translational arrest, through the IFN signaling path-
way, called the JAK-STAT pathway (5). In the case of stim-
ulation by type-I IFN, the IFN-stimulated gene factor 3
(ISGF3) complex consisting of transcription factors, sig-
nal transducers and activators of transcription (STAT)1,
STAT2 and IFN regulatory factor 9 (IRF9) bind to ISREs
in the ISG promoters, facilitating transcription initiation
complex formation and thereby promoting the transcrip-
tion of ISGs (3,5). In addition, ISG transcription is regu-
lated by several different kinds of coactivators (4). STATs
interact with histone acetyltransferases (HATs), including
p300/CBP and GCN5, and GCN5 acetylates histones on
the ISG promoter in an IFN-dependentmanner (6,7). Inter-
estingly, inhibition of histone deacetylase (HDAC) activity,
which opposes activity of HAT, leads to a global impair-
ment of the ISG transcription (8–10). In addition, pp32, a
major component of the inhibitor of acetyltransferase (IN-
HAT) complex (11), is involved in the maximal induction of
ISG transcription (12). BRG1, an adenosine triphosphate
(ATP)-dependent nucleosome remodeling factor and a sub-
unit of the SWI/SNF complex, interacts with STAT2 in
response to IFN, facilitates the chromatin remodeling of
the ISG promoter region and promotes ISG transcription
(13–15). BAF200, a subunit of the SWI/SNF complex, has
been found to be required for selective ISG transcription
(16). These studies suggest that ISG transcription via ISG
promoters is under the control of the combined effects of
histone modification and specific chromatin structures. As
proteins encoded by ISGs not only have anti-viral activities
but also affect host-cellular events (5), the ISG transcrip-
tion needs to be silenced in the IFN-unstimulated condi-
tion. However, it is unclear as to how the chromatin struc-
ture of ISG promoters is regulated to be in the unstimulated
state, namely the transcriptionally silent state, in the absence
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of IFN, and what kind of factors maintain the transcrip-
tionally silent state of the ISG promoter remains unknown.
Linker histone H1 binds near to the entry and exit sites
of the nucleosome core particle (NPC), which consists of
a 147-base-pair (bp)-long deoxyribonucleic acid (DNA),
wrapped around a histone octamer consisting of two copies
each of the core histone proteins H2A, H2B, H3 and H4,
and facilitates the higher order chromatin structure (17–
19). Histone H1-dependent chromatin dynamics have been
shown to be important in a variety of biological phenomena
and in the transcriptional regulation of a certain gene (20–
24). In addition, fluorescence recovery after photobleach-
ing analyses demonstrated that histone H1 is a highly mo-
bile chromatin component compared with the core histones
and that the binding of histone H1 onto the nucleosome
is transient (25,26). These findings suggest that histone H1
continuously associates with and dissociates from the chro-
matin, but it is unclear as to what kind of mechanisms and
factors are involved in regulating histone H1 dynamics and
H1-dependent chromatin structural alterations.
Several factors are involved in the regulation of histone
H1 dynamics. High mobility group proteins weaken the
binding of histone H1 to the nucleosome by dynamically
competing for chromatin binding sites (27). Histone variant
H3.3, which is incorporated into nucleosomal chromatin
in association with active gene expression, counteracts the
association of histone H1 (28). In addition to these pro-
teins, template activating factor-I (TAF-I, also known as
SET) regulates histone H1 dynamics as a histone chaperone
(29). TAF-I was first identified as a stimulator of adenovirus
DNA replication in vitro, and subsequent studies revealed
that TAF-I acts as a histone chaperone for histones H3-H4
and linker histone H1 (29–33). TAF-I is associated with hi-
stone H1 in mammalian somatic nuclei and shows histone
H1 chaperone activity in vitro (29).
In this study, we identified a novel mechanism for the
silencing of ISG transcription by histone H1 and TAF-
I. TAF-I knockdown (KD) facilitates ISG transcription
during the early stages of transcription following IFN-
mediated induction from the transcriptionally silent state.
In TAF-I KD cells, the transcription factor levels on the
ISG promoterwere increased during the early stages of tran-
scription following IFN induction, and the amount of his-
tone H1 on the ISG promoter was significantly decreased
from the transcriptionally silent state to the early stages
of transcription following IFN induction. The domain of
TAF-I that is essential for the histone H1 chaperone activ-
ity was also required for the TAF-I functions in ISG tran-
scription. Histone H1 KD increased ISG transcription, as
did TAF-I KD. Double TAF-I and histone H1 KD did not
additively affect ISG transcription. The micrococcal nucle-
ase (MNase) sensitivity of the ISG promoter was increased
in both TAF-I KD and histone H1 KD. Taking these find-
ings together, we propose that TAF-I recruits histone H1
to the ISG promoter through its histone H1 chaperone ac-
tivity, suppresses transcription complex formation on the
ISG promoter and restricts aberrant transcription under the
transcriptionally silent state.
MATERIALS AND METHODS
Cell culture and antibodies
HeLa S3 and HEK293 cells were grown in Dulbecco’s
modified essential medium supplemented with 10% fetal
calf serum. Antibodies used in this study are as follows:
Anti-STAT1/ (sc-346; Santa Cruz Biotechnology), anti-
STAT2 (sc-476; Santa Cruz Biotechnology), anti-IRF9 (sc-
10793; Santa Cruz Biotechnology), anti-phospho-(Tyr701)
STAT1 (#9171; Cell Signaling Technology), anti-phospho-
(Tyr689) STAT2 (#07-224; Upstate Biotechnology), anti-
phospho-(Ser727) STAT1 (#06-802; Upstate Biotechnol-
ogy), anti-Pol II (sc-899; Santa Cruz Biotechnology), anti-
-Actin (A5441; SIGMA), anti-Histone H3 (ab1791; Ab-
cam), anti-acetyl-Histone H3 (06-599; Millipore), anti-
HistoneH1.2 (ab4086;Abcam), anti-Flag (F3165; SIGMA)
and anti-TAF-I/ (monoclonal antibody KM1725) (34)
antibodies.
Preparation of plasmids
To construct plasmids expressing short interfering RNA
(siRNA)-resistant Flag-TAF-I, Flag-TAF-IC, Flag-
TAF-I and Flag-TAF-IC, DNA fragments were
amplified by polymerase chain reaction (PCR) us-
ing plasmids expressing His-TAF-I and His-TAF-I
(29) as templates and the following primer sets: 5′-
GCGGATCCATGGCCCCTAAACGCCAGTC-3′ and
5′-ATGTGCTCTATTGCCTCCTGTTGTTCTTTTTC
TCCCTTCTTCG-3′ for the N-terminal region of TAF-I
(N), 5′-GCGGATCCATGTCGGCGCAGGCGGCC
AA-3′ and 5′-ATGTGCTCTATTGCCTCCTGTTGTTC
TTTTTCTGAGGTCTCGTC-3′ for the N-terminal region
of TAF-I (N) and 5′-ACAGGAGGCAATAGAG
CACATTGATGAAGTACAAAATGAAATAG-3′ and
5′-GCGAATTCTTAGTCATCTTCTCCTTCAT-3′ for
the C-terminal region of TAF-I/ (C/). To generate
full-sized TAF-I/ and TAF-I/C complementary
DNA (cDNA), PCR was performed using N or N
and C/ as templates and the following primer sets:
5′-GCGGATCCATGGCCCCTAAACGCCAGTC-3′ and
either 5′-GCGAATTCTTAGTCATCTTCTCCTTCAT-3′
for full-sized TAF-I or 5′-GCGAATTCTTACATAT
CGGGAACCAAGTAGT-3′ for TAF-IC, and 5′-
GCGGATCCATGTCGGCGCAGGCGGCCAA-3′ and
either 5′-GCGAATTCTTAGTCATCTTCTCCTTCAT-3′
for full-sized TAF-I or 5′-GCGAATTCTTACATATCG
GGAACCAAGTAGT-3′ for TAF-IC. The amplified
cDNA fragments were digested with BamHI and EcoRI
and cloned into pcDNA3.1(+)-Flag vector that had been
digested with same enzymes. pU6-puro-siTAF-I and
pU6-puro-siEGFP plasmids, which express 21-nucleotide-
long hairpin-type siRNAs against TAF-I and EGFP,
respectively, under the control of the U6 promoter were
described previously (35,36). To generate pU6-puro-siH1
plasmid, which expresses 21-nucleotide-long hairpin-type
siRNA against histone H1.2, 5′-terminal oligonucleotides,
5′-CACCGCTTCTTTAGACTTAACAGGAGTGTGCT
GTCCTCTTGTTGAGTTTAAAGGAGCTTTTT-3′ and
5′-GCATAAAAAGCTCCTTTAAACTCAACAAGAGG
ACAGCACACTCCTGTTAAGTCTAAAGAAGC-3′
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were phosphorylated, annealed each other and cloned into
pU6-puro (36) that had been digested with BspMI.
siRNA-mediated KD and western blot analysis
Cells were transfected with pU6-puro-siTAF-I, pU6-puro-
siH1 or pU6-puro-siEGFP using Gene Juice (Novagen) ac-
cording to the manufacturer’s protocol. After 16 h post
transfection, puromycin was added in the medium at the
concentration of 2 g/ml and cells were further incubated
for 20–24 h. After selection in the presence of puromycin,
cells were transferred to the medium in the absence of
puromycin and further incubated for 48 h. siRNAs against
TAF-I and histone H1.2 were commercially purchased
(Stealth siRNA; Invitrogen). siRNAs were introduced into
HeLa S3 cells with Lipofectamine RNAiMAX (Invitrogen)
according to the manufacturer’s protocol. Negative con-
trol Stealth siRNA (12935-200; Invitrogen) was used as a
negative control. Cells were lysed in a cell lysis buffer [10-
mM Tris-HCl, pH 7.9, 300-mM NaCl, 1-mM ethylenedi-
aminetetraacetic acid (EDTA), 1% NP-40, 10% glycerol,
5-mM -D-glycerophosphate, 1-mM sodium fluoride, 1-
mM sodium orthovanadate and 1-mM phenylmethylsul-
fonyl fluoride (PMSF)] and incubated at 4◦C for 30minwith
constant rotation. After centrifugation, the supernatant
fraction was separated on 7.5–12.5% sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
and electroblotted to a nitrocellulose membrane. Nitrocel-
lulose membranes were incubated with specific antibod-
ies, followed by incubation with horseradish peroxidase-
conjugated goat anti-rabbit antibodies (Amersham), bi-
otinylated anti-rabbit Ig (Amersham) or biotinylated anti-
mouse Ig (Amersham). Streptavidin-alkaline phosphatase
(Amersham) or streptavidin-horseradish peroxidase (Amer-
sham) was used for detection of biotinylated Igs.
Total RNA extraction and quantitative real-time PCR
Total RNAwas prepared from cells treated with or without
IFN- (1000 IU/ml; Toray) using RNeasy minikit (Qiagen)
and RNase-free DNase I (Qiagen), and subjected to reverse
transcription using SuperScript III Reverse Transcriptase
(Invitrogen) with oligo-dT primer. Synthesized cDNA
was used for quantitative real-time PCR (qRT-PCR)
using FastStart SYBR Green Master (Roche) with spe-
cific primer sets, 5′-CAGATCACCCAGAAGATCG-3′
and 5′-CCCTTGTTATTCCTCACCAG-3′ for ISG15
mRNA, 5′-ACACCTGAAAGGCCAGAATGAGGA-3′
and 5′-TGCCAGTCTGCCCATGTGGTAATA-3′ for
ISG56 mRNA, 5′-GTTACTGGTATTCGGCTCTG-3′
and 5′-GGTGTGTGGGTATAAACTGC-3′ for IFITM1
mRNA, 5′-GACACGGTTAAAGTGTGGAG-3′ and
5′-GGTACTGGTTGTCAGGATTC-3′ for ISG54
mRNA, 5′-AAACCAAGGCACAGTGGAAC-3′ and
5′-TAGCAAAATTGAGGCCAAGG-3′ for IL8 mRNA,
5′-CTCCGAGACTTTCGAGGAAATAC-3′ and 5′-
GCCATTGTAGTTGGTAGCCTTCA-3′ for IκBα
mRNA, 5′-AGCCAAAAGGGTCATCATCTC-3′ and
5′-GGACTGTGGTCATGAGTCCTTC-3′ for GAPDH
mRNA and 5′-AGCCAGTGCCTTGTGTGT-3′ and 5′-
CAGCTCTGACACCGACAT-3′ for ISG15 pre-mRNA.
Chromatin immunoprecipitation assay
Cells were treated with or without IFN- (1000 IU/ml) or
trichostatin A (TSA, 0.1 or 1 M; SIGMA) for indicated
periods followed by fixation with 1% formaldehyde at
room temperature for 15 min. Fixation was quenched
by the addition of glycine at the final concentration of
125 mM, and cells were washed twice with phosphate
buffered saline (PBS). Cells were swollen for 10 min in a
hypotonic lysis buffer (20-mM HEPES-NaOH, pH 7.9,
10-mMKCl, 1.5-mMMgCl2, 0.5-mMdithiothreitol (DTT)
and 0.2% NP-40) and collected in a 1.5-ml tube. After
centrifugation, nuclear pellets were lysed in chromatin
immunoprecipitation (ChIP) lysis buffer (50-mMTris-HCl,
pH 7.9, 1% Triton X-100, 0.1% SDS, 0.1% deoxycholic
acid, 10-mM EDTA, 5-mM -D-glycerophosphate, 1-mM
sodium fluoride, 1-mM sodium orthovanadate and 1-mM
PMSF), subjected sonication to shear the chromatin to
∼500-bp-long DNA in size, and diluted with four volumes
of ChIP dilution buffer (12.5-mM Tris-HCl, pH 7.9,
187.5-mM NaCl and 1% TritonX-100). Clarified lysates
by centrifugation were incubated with each antibody or
anti-FlagM2 affinity gel (SIGMA) slurry at 4oC overnight.
Antibody-protein–DNA complexes were incubated with
Protein A Sepharose 4 Fast Flow (Amersham) and washed
with a low salt wash buffer (20-mM Tris-HCl, pH 7.9,
100-mM NaCl, 2-mM EDTA, 0.1% SDS and 1% Triton
X-100), with a high salt wash buffer (20-mM Tris-HCl,
pH 7.9, 500-mM NaCl, 2-mM EDTA, 0.1% SDS and 1%
Triton X-100), with a LiCl buffer (10-mM Tris-HCl, pH
7.9, 250-mM LiCl, 1% NP-40, 1% deoxycholate acid and
1-mM EDTA), and twice with Tris-EDTA (TE), succes-
sively. Then, bound proteins were eluted from the beads
in an elution buffer (1% SDS and 100-mM NaHCO3) by
incubation at room temperature for 15 min. Cross-linking
was reversed by incubation at 65◦C overnight. All samples
were treated with 40 g/ml of Proteinase K (Nacalai
Tesque) at 55◦C for 2 h, and then DNA was extracted
with phenol:chloroform:isoamyl alcohol and precipitated
with ethanol. DNA fragments were subjected to qRT-PCR
using FastStart SYBR Green Master (Roche) with specific
primer sets, 5′-CATGCCTCGGGAAAGGGAAAC-
3′ and 5′-GTGACATCTGCCTTACCATGG-
3′ for the ISG15 promoter (−123/+96), 5′-
GCAGGAATTCCGCTAGCTTT-3′ and 5′-
ATCCTTACCTCATGGTTGCTG-3′ for the ISG56 pro-
moter (−138/+103), 5′-ACCTCATTGGTCCCTGGCTA-
3′ and 5′-AGAAGTGTGGTTTTCTGCGT-
3′ for the IFITM1 promoter (−214/−39), 5′-
ACTCAGGTTTGCCCTGAGGGA-3′ and 5′-
TGCCTTATGGAGTGCTCCGGTG-3′ for the IL8 pro-
moter (−124/+12), 5′-GCTCAGGGTTTAGGCTTCTT-
3′ and 5′-TATAAACGCTGGCTGGGGAT-
3′ for the IκBα promoter (−139/−13) and 5′-
TCGGTGCGTGCCCAGTTGAACCAG-3′ and 5′-
AACAGGAGGAGCAGAGAGCGAAGC-3′ for the
GAPDH promoter (−212/+18).To measure the amount of
TAF-I on the chromatin, HeLa S3 cells transfected with
pU6-puro-siTAF-I together with siRNA-resistant Flag-
TAF-I expression vector were subjected to puromycin
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selection. In this TAF-I KD/rescure condition, ChIP
assays were carried out as described above.
MNase protection assay
Cells (∼1 × 106) were treated with or without IFN- (1000
IU/ml) for indicated periods followed by fixation with 1%
formaldehyde at room temperature for 15min. Fixationwas
quenched by the addition of glycine at the final concentra-
tion of 125 mM, and cells were washed twice with ice-cold
PBS. The cells were then collected by centrifugation, resus-
pended in 1.5ml of Buffer A (300-mM sucrose, 35-mMTris-
HCl, pH 7.9, 15-mM NaCl, 5-mMMgCl2, 60-mM KCl, 3-
mM CaCl2, 0.2% Triton X-100) and incubated at 4oC for
10 min. The pellet was collected by centrifugation and re-
suspended in 1.4 ml of MNase Buffer (35-mM Tris-HCl,
pH 7.9, 15-mM NaCl, 5-mM MgCl2, 60-mM KCl, 3-mM
CaCl2, 12.5% glycerol), and then chromatin suspension was
prepared. The chromatin suspension was divided into two
aliquots (300 ul), and 30 units MNase were added to one
aliquot. Both aliquots were incubated at room temperature
for 5 min with constant rotation, and then EDTA (25 mM
at the final concentration) and SDS (1% at the final con-
centration) were added to stop the reaction. Cross-linking
was reversed by incubation at 65◦C overnight. All samples
were treated with Proteinase K and RNase A to digest pro-
teins and residual RNA, respectively. DNA was extracted
with phenol:chloroform:isoamyl alcohol and precipitated
with ethanol. DNA fragments were subjected to qRT-PCR
using FastStart SYBR Green Master (Roche) with specific
primer sets as shown in the ‘Chromatin immunoprecipita-
tion assay’ section of the Materials and Methods section.
Reporter gene assay
HEK293 cells were transfected with pU6-puro-siTAF-I or
pU6-puro-siEGFP together with pISRE-TA-Luc (Clon-
tech) containing the ISRE and pSEAP-Control (Clontech)
using Gene Juice (Novagen) according to the manufac-
turer’s protocol. At 48 h post transfection, cells were treated
with or without IFN- (1000 IU/ml) for 6 h. Cell lysates
were used for assays of the luciferase activity using the lu-
ciferase assay system (Promega) and a MiniLumat LB9506
luminometer (Berthhold). To monitor the transfection effi-
ciency, a portion of each cell culture medium was assayed
for secreted alkaline phosphate (SEAP) using the SEAP as-
say kit (Toyobo).
RESULTS
TAF-I is involved in ISG transcriptional regulation
To study the involvement of TAF-I in ISG transcription, we
first examined the effect of TAF-I KD on ISG transcrip-
tion. TAF-I consists of two subtypes, TAF-I and TAF-I.
They have common structures except for a 37 amino acid
(aa) amino-terminal region of TAF-I that differs from a
24 aa amino-terminal region of TAF-I (33). In TAF-I KD
cells (see the Materials and Methods section), the levels of
the TAF-I proteins were∼25%of those in control cells (Fig-
ure 1A). To examine the effects of the reduction of TAF-I
on the transcriptional induction of ISGs, total RNA was
isolated from cells and subjected to qRT-PCR with primer
sets specific for ISGmRNAs (ISG15, ISG56 and IFITM1).
The ISG mRNA levels induced by IFN stimulation were
significantly higher in TAF-I KD cells than in control cells
(Figure 1B).We also observed the same effect in other TAF-
I KD cells transfected with siRNA against TAF-I, targeting
a region of TAF-I different from that of the vector express-
ing siRNA against TAF-I used for the analysis in Figure 1
(Supplementary Figure S1A and B). Note that the increases
in ISG mRNAs in TAF-I KD cells were observed not only
in an IFN-stimulated condition but also in an unstimulated
condition. Kinetic analysis showed that the levels of ISG15
mRNA and ISG15 pre-mRNA were found to be signifi-
cantly higher in TAF-I KD cells than those in unstimulated
cells at the early stages following IFN induction (Figure
1C). The mRNA levels of the other ISGs also showed simi-
lar effects in a time-dependentmanner (Supplementary Fig-
ure S1C). These results indicate that TAF-I negatively reg-
ulates ISG transcription and suggest that TAF-I could be
involved in the maintenance of the transcriptionally silent
state of ISGs.
TAF-I does not affect STAT phosphorylation and ISRE-
dependent transcription
To clarify the role of TAF-I in transcriptional regulation, we
examined the effect of TAF-I on the IFN signaling path-
way leading to transcriptional activation. IFN stimulates
the JAK-STAT pathway and induces the phosphorylation
of STAT1 and STAT2, leading to the formation of STAT1-
STAT2 heterodimers, together with IRF9, forms the ISGF3
complex. The ISGF3 complex binds to ISREs near the ISG
promoters, facilitates transcription initiation complex for-
mation and thereby promotes the transcription of ISGs (3).
The phosphorylation of STAT2 at tyrosine 690 and that
of STAT1 at tyrosine 701 are required for STAT1-STAT2
heterodimerization and ISGF3 complex formation, and,
additionally, the phosphorylation of STAT1 at serine 727
stimulates activation of ISG transcription (5). To examine
whether TAF-I affects the phosphorylation state of STATs,
we performed western blot analysis using antibodies spe-
cific for each phosphorylated STAT. There were no signif-
icant differences in the levels of tyrosine phosphorylated
STAT1 and STAT2, serine phosphorylated STAT1 or in the
amounts of STAT1, STAT2 and IRF9 between TAF-I KD
and control cells (Figure 2A), suggesting that TAF-I does
not affect the IFN-induced STAT activating cascade.
To examine whether TAF-I affects the ISRE-dependent
transcription directly, we performed reporter gene assays
using pISRE-TA-Luc, encoding the luciferase (Luc) gene
under the control of the ISRE, which is responsible for
Type I IFN stimulation. There was no significant change
in luciferase activity between the control and TAF-I KD
cells (Figure 2B), indicating that TAF-I does not play a di-
rect role in ISRE-dependent transcription regulated by the
ISGF3 complex. This seems to contradict the results pre-
sented in Figure 1, where the ISG mRNA levels were in-
creased in TAF-I KD cells. Transcription from transiently
transfected genes and stably integrated genes is expressed
differently due to nucleosome structure (37–39), the as-
sociation with histone H1 with the chromatin (40) and
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Figure 1. TAF-I negatively regulates ISG transcription. (A) Expression level of TAF-I in TAF-I KD cells. HeLa S3 cells were transfected with EGFP
siRNA expression vector used as a control (siCont, lanes 1–3) or with TAF-I siRNA expression vector (siTAF-I, lane 4). Cell lysates were subjected to
western blot analysis using anti-TAF-I and anti--actin antibodies. (B) and (C) Effects of TAF-I KD in ISG transcription. Total RNA was prepared from
siCont- and siTAF-I-transfected cells treated with or without IFN- for 3 h (B) or for indicated periods (C) and subjected to qRT-PCRusing specific primer
sets for ISGmRNAs, ISG15 pre-mRNA and GAPDHmRNA. The amount of ISGmRNA was normalized as a relative amount of GAPDHmRNA. The
amounts of ISG15 mRNA and ISG15 pre-mRNA in TAF-I KD cells relative to those of control cells were shown in the right panel of (C). Error bars
represent standard deviation (n ≥ 3). *P < 0.01, **P < 0.001 by two-tail-paired Student’s t-test (n = 8).
the effects of the distal elements on the chromatin (41).
Because TAF-I possesses histone chaperone activity (29–
31), and it is a major component of the INHAT complex
(11), we hypothesized that TAF-I may control ISG tran-
scription through chromatin structure regulation. The C-
terminal acidic domain common to TAF-I and  is es-
sential for its histone chaperone activity and INHAT activ-
ities (11,29–31,33). We constructed expression vectors for
TAF-IC mutants lacking the acidic domain (Figure 2C)
and performed rescue experiments to examine whether the
histone chaperone activity and/or INHAT activity are es-
sential for the effects of TAF-I on ISG transcription. The
expression of siRNA target sequence-modified Flag-tagged
TAF-Is was observed in TAF-I siRNA expression vector-
transfected cells (Figure 2D), and the ISG transcription that
was enhanced by TAF-I KD was repressed by wild-type
TAF-I but not TAF-IC (Figure 2E), indicating that the
acidic domain of TAF-I, which is essential for the histone
chaperone activity, plays a role in the regulation of the ISG
transcription.
The levels of transcription factors and histone H1 on the ISG
promoters are regulated by TAF-I
To examine whether TAF-I affects transcriptional complex
formation on endogenous ISG promoters, we performed
ChIP assays to measure the amounts of STAT1, STAT2
and Pol II in the TAF-I KD in the presence or absence of
IFN. At the early time point, following IFN stimulation,
the levels of STAT1, STAT2 and Pol II bound to the ISG
promoters were elevated in TAF-I KD cells, compared to
control cells (Figure 3A and Supplementary Figure S2A).
This was in good agreement with the effects seen for TAF-I
KDon ISG transcription. These findings suggest that TAF-
I affects transcriptional complex formation on the ISG pro-
moter.
We predict that above effects were brought about byTAF-
I-mediated changes in the chromatin structure. Thus, we
performed ChIP assays using antibodies against histone
H3 (H3) and acetylated-histone H3 (H3K9/14Ac), the lat-
ter of which is known to be associated with actively tran-
scribed genes and the acetylation level of which is regu-
lated by promoter-associated HATs such as p300/CBP and
GCN5 (42). qRT-PCR analyses indicated no significant dif-
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Figure 2. The acidic domain of TAF-I is essential for ISG transcriptional regulation. (A) IFN-responsive STAT phosphorylation in TAF-I KD cells. Cell
lysates were prepared from siCont- (lanes 1–4) and siTAF-I-transfected (lanes 5–8) cells treated with or without IFN- for indicated periods, and subjected
to western blot analysis using anti-tyrosine phosphorylated (pY)-STAT1, anti-pY-STAT2, anti-serine phosphorylated (pS)-STAT1, anti-STAT1, anti-
STAT2, anti-IRF9, anti-TAF-I and anti--actin antibodies. (B) Dispensability of TAF-I in ISRE-dependent transcription. HEK293 cells were transfected
with EGFP siRNA expression vector used as a control (siCont) or with TAF-I siRNA expression vector (siTAF-I) together with pISRE-TA-Luc and
pSEAP-control, and then cells were treated with or without IFN- for 6 h followed by the luciferase assay. The luciferase activity was normalized with
the SEAP activity and represented as fold-induction relative to that from IFN-treated control cells. Error bars represent standard deviation (n ≥ 3). ‘n/s’
indicates ‘not significant’. (C) Schematic representation of TAF-I proteins. The N-terminal regions specific for TAF-I (aa 1–37) and TAF-I (aa 1–24)
and the C-terminal acidic region for TAF-I (aa 239–290) and TAF-I (aa 226–227) are indicated. (D) Expression level of Flag-TAF-Is in TAF-I KD cells.
Cell lysates were prepared from HeLa S3 cells transfected with EGFP siRNA expression vector used as a control (lanes 1–3) or TAF-I siRNA expression
vector (siTAF-I, lanes 4–8) together with expression vectors expressing Flag-tagged TAF-I (lane 5), Flag-tagged TAF-IC (lane 6), Flag-tagged TAF-I
(lane 7), Flag-tagged TAF-IC (lane 8) or empty vector (lane 4), and cell lysates were subjected to western blot analysis using anti-TAF-I, anti-Flag and
anti--actin antibodies. (E) Transcription rescue experiments by Flag-TAF-I. Cells were prepared as shown in (D) and treated with or without IFN- for
3 h. Total RNA was subjected to qRT-PCR using specific primer sets for ISG15 mRNA (left), ISG56 mRNA (right) and GAPDH mRNA. The amount
of ISG mRNA was normalized as a relative amount of GAPDH mRNA. Error bars represent standard deviation (n ≥ 3). *P < 0.05, **P < 0.01 by
two-tail-paired Student’s t-test (n = 6).
ferences in the amounts of histone H3 on ISG promoters
when treated with or without IFN, between TAF-I KD
cells and control cells. The amount of acetylated histone
H3 in TAF-I KD cells remained unchanged from that in
control cells in the absence of IFN, but upon IFN stimu-
lation, acetylated histone H3 increased in TAF-I KD cells
during the early time (Figure 3B and Supplementary Fig-
ure S2B). Because STAT interacts with HATs and recruits
them to ISG promoters in an IFN-dependent manner (6),
the increased amount of acetylated-histone H3 in TAF-I
KD cells may be due to an increased amount of STAT on
the ISG15 promoter (Figure 3A). Furthermore, ChIP as-
says using an antibody against linker histoneH1.2 (H1), one
of the histone H1 subtypes highly expressed in HeLa cells
(43) and that is associated with TAF-I in vivo (29), demon-
strated that the amount of histone H1 on ISG promoters
in TAF-I KD cells was significantly reduced in the absence
of IFN as well as early time point upon IFN stimulation
(Figure 3B and Supplementary Figure S2B). These results
suggest that TAF-I regulates the amount of histone H1 on
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Figure 3. TAF-I regulates the amounts of the transcription factors and histone H1 on ISG promoters. (A) Promoter binding of transcription factors
in TAF-I KD cells. siCont- and siTAF-I-transfected cells were treated with or without IFN- for indicated periods, and cell lysates were subjected to
ChIP assays using antibodies specific for STAT1 (left), STAT2 (middle) and Pol II (right) followed by qRT-PCR using a specific primer set for the ISG15
promoter. The amount of DNA co-immunoprecipitated with each antibody was shown as % of input. Error bars represent standard deviation (n ≥ 3).
*P < 0.05, **P < 0.01 by two-tail-paired Student’s t-test (n = 6). (B) Decrease of histone H1 levels on the ISG promoter in TAF-I KD cells. Cells were
prepared as shown in (A) and cell lysates were subjected to ChIP assays using antibodies specific for histone H3 (H3), acetylated histone H3 (H3K9/14Ac)
and histone H1.2 (H1) followed by qRT-PCR using specific primer sets for the ISG15 promoter. The amount of DNA co-immunoprecipitated with each
antibody was shown as % of input. Error bar represents standard deviation (n ≥ 3). *P < 0.05, **P < 0.01 by two-tail-paired Student’s t-test (n = 6).
the ISG promoter but does not act as a histoneH3-H4 chap-
erone or an INHAT in ISG transcription.
Linker histone H1 is involved in ISG transcriptional regula-
tion
Next, we addressed the question of whether histone H1 reg-
ulates ISG transcription. We prepared histone H1 KD cells
using a histoneH1 siRNA expression vector. Using this vec-
tor, the residual level of histoneH1 protein in the histoneH1
KD cells was observed to be ∼25% that of the control cells
(Figure 4A). To examine the effects on transcriptional in-
duction of ISGs, we measured the levels of ISG mRNAs in
histone H1KD cells. The ISGmRNA level was increased in
histoneH1KD cells compared to that in the control cells, as
it was in TAF-I KD cells (Figure 4B). We also observed the
same effects in histone H1KD cells transfected with siRNA
against histone H1.2 that targets a region of histone H1.2
different from that of siRNA expression vector used for the
analysis in Figure 4 (Supplementary Figure S3). These re-
sults indicate that histone H1 acts as a negative regulator of
ISG transcription, which correlated well with the decreased
amount of histone H1 on the ISG promoter in TAF-I KD
cells (Figure 3B). Furthermore, we examined the effects of
a double KD of TAF-I and histone H1 on ISG transcrip-
tion (Figure 4C). The ISG mRNA level was increased in
TAF-I and histone H1 KD cells, but no additive effect was
observed in the double KD cells, suggesting that TAF-I and
histone H1 may act in the same pathway during the process
of ISG transcription. Furthermore, to determine whether
the level of histoneH1 on the ISG promoter affects the chro-
matin binding of TAF-I, wemeasured the amount of TAF-I
on the ISG promoter in histone H1 KD cells (Figure 4D).
The amount of histone H1 was significantly decreased on
the ISG promoter in histone H1 siRNA-transfected cells
(Figure 4D, right panel), while the amount of TAF-I was
unchanged in histone H1 KD and the control cells (Figure
4D, left panel). These results suggest that histoneH1 on ISG
promoters does not affect chromatin binding of TAF-I.
TAF-I and histone H1 affect the chromatin structure at the
ISG promoter
Based on the above results, it is reasonable to postulate that
TAF-I regulates the amount of histone H1 on ISG promot-
ers and that ISG transcription is negatively controlled by
histone H1 in the transcriptionally silent state and during
the early stage of ISG transcription induced by IFN stimu-
lation. Histone H1 plays a role in the formation of the chro-
matin structure at several promoter regions (44–46). To ex-
amine if TAF-I and histone H1 are involved in modulating
the chromatin architecture near ISG promoters, we carried
out MNase protection assays, to monitor the compactness
of the chromatin in TAF-I KD and histone H1 KD cells
(47,48). Overall DNA digestion patterns (nucleosome re-
peat lengths) seemed to be similar in all cases, suggesting
that KD of TAF-I and histone H1.2 or the IFN treatment
does not affect the genome-wide nucleosome structure (Fig-
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Figure 4. Histone H1 negatively regulates ISG transcription. (A) Expression level of histone H1 in histone H1 KD cells. HeLa S3 cells were transfected
with EGFP siRNA expression vector used as a control (siCont, lanes 1–3) or histone H1 siRNA expression vector (siH1, lane 4). Cell lysates were subjected
to western blot analysis using anti-histone H1.2 (H1) and anti--actin antibodies. (B) Effects of histone H1 KD on ISG transcription. Total RNA was
prepared from siCont- and siH1-transfected cells treated with or without IFN- for 3 h and subjected to qRT-PCR using specific primer sets for each ISG
mRNAandGAPDHmRNA. The amount of ISGmRNAwas normalized as relative amounts ofGAPDHmRNA. Error bars represent standard deviation
(n ≥ 3). *P < 0.05, **P < 0.01 by two-tail-paired Student’s t-test (n = 4). (C) Genetic interaction between TAF-I and histone H1 in the ISG transcription
regulation. HeLa S3 cells were transfected with EGFP siRNA expression vector (lanes 1 and 5) and TAF-I siRNA expression vector (lanes 2, 4, 6 and
8) together with or without histone H1 siRNA expression vector (lanes 3, 4, 7 and 8), and then treated with or without IFN- for 3 h. Total RNA was
subjected to qRT-PCR using specific primer sets for ISGmRNAs and GAPDHmRNA. The amount of ISGmRNA was normalized as a relative amount
of GAPDHmRNA. Error bars represent standard deviation (n ≥ 3). (D) Binding of TAF-I on ISG promoters in histone H1 KD cells. HeLa S3 cells were
transfected with TAF-I siRNA expression vector (lanes 1–5) together with empty vector (lane 3) or Flag-tagged TAF-I expression vector (lanes 1, 2, 4
and 5), and then transfected with siRNA specific for histone H1.2 (lanes 2 and 5) or negative control siRNA (lanes 1 and 4). Cells were, then, subjected to
ChIP assays using the agarose-conjugated antibody against Flag (Flag) and an antibody specific for histone H1.2 (H1) followed by qRT-PCR using specific
primer sets for ISG promoters. The amount of DNA co-immunoprecipitated with each antibody was shown as % of input. Error bars represent standard
deviation (n ≥ 3). *P < 0.001 by two-tail-paired Student’s t-test (n = 6).
ure 5A). Thus, the depletion levels of histone H1.2 in this
experimental condition may not be enough to induce the
significant changes of the genome-wide nucleosome repeat
length as reported in the previous report (49), and it is pos-
sible that the positioning of histone H1 via TAF-I is not
a genome-wide mechanism, but is instead restricted to the
chromatin of certain genes. We then performed qRT-PCR
using primers covering ISG promoter regions to determine
the sensitivity to MNase digestion. The amount of residual
genomic DNA from the MNase digestion was significantly
reduced in TAF-I and histone H1 KD cells compared to
control cells in the transcriptionally silent state and during
the early stage of transcription induced by IFN stimulation
(Figure 5B and Supplementary Figure S4). These results
suggest that TAF-I recruits histone H1 onto ISG promot-
ers and hence acts to maintain a relatively close chromatin
structure near the ISG promoter region to prevent loading
of the transcriptional machinery and/or transcription by
Pol II.
TAF-I is associated with ISG promoters in the transcription-
ally silent state, but dissociated during the early stage of tran-
scription induced by IFN stimulation
To clarify the dynamics of TAF-I in ISG transcription, we
investigated how TAF-I associates with the ISG promoter.
TAF-I was associated with the ISG promoter in the tran-
scriptionally silent state and was gradually released follow-
ing IFN stimulation (Figure 6A). It is quite possible that the
decrease in TAF-I results in a reduction of the amount in
histone H1 on ISG promoter regions in an IFN-dependent
manner (Figure 3B). Previous studies have shown that TAF-
I tends to interact with unacetylated and hypoacetylated,
but not with hyperacetylated histones (50). We showed that
the acetylated histone level is increased at the ISG promoter
in IFN-treated cells (Figure 3B). Based on these results, we
hypothesized that the acetylated histone induced by IFN
treatment would restrict binding of TAF-I to the ISG pro-
moter. To test this hypothesis, we performed ChIP assays
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Figure 5. TAF-I and histone H1 regulate the chromatin structure of ISG promoters. (A) Nucleosome digestion by MNase. HeLa S3 cells were transfected
with EGFP siRNA expression vector (siCont, lanes 1–4), TAF-I siRNA expression vector (siTAF-I, lanes 5–8) and histone H1 siRNA expression vector
(siH1, lanes 9–12), and then treated with or without IFN- for indicated periods followed by the fixation with formaldehyde. MNase digestion was carried
out as described in theMaterials andMethods section, and then genomicDNAswere purified, separated by electrophoresis in 1% agarose gel and visualized
by ethidium bromide staining. Lane M shows DNA size markers. (B) Increase of the MNase sensitivity of the ISG15 promoter in TAF-I KD and H1 KD
cells. MNase-digested DNAwas prepared as shown in (A) and subjected to qRT-PCR using specific primer sets for the ISG15 andGAPDH promoters. The
amount of the ISG15 promoter DNAwas normalized by that of theGAPDH promoter DNA and is shown as a relative amount to that from IFN-untreated
control cells. Error bars represent standard deviation (n ≥ 3). *P < 0.0001 by two-tail-paired Student’s t-test (n = 9).
using chromatin prepared from HeLa S3 cells treated with
TSA, an HDAC inhibitor, to maintain high levels of his-
tone acetylation at the ISG promoter (Figure 6B and Sup-
plementary Figure S5A). Indeed, TSA treatment promoted
histone H3 acetylation. Furthermore, the amount of his-
tone H1 on the ISG15 promoter was significantly decreased
in TSA-treated cells compared to mock-treated cells. Un-
der these conditions, we also measured the amount of TAF-
I bound to the ISG promoter, using cells prepared by the
same method as for Figure 6A followed by TSA treatment.
The level of TAF-I bound to the ISG promoter was signif-
icantly decreased in the TSA-treated cells (Figure 6C and
Supplementary Figure S5B). A possible interpretation of
these results is that the acetylated histone induced by IFN
treatment restricts TAF-I from binding to the ISG pro-
moter, which in turn prevents histone H1 recruitment onto
the ISG promoter during the late stages of the ISG tran-
scription.
DISCUSSION
In this study, we clarified the functional interplay between
TAF-I and histone H1 in the silencing of ISG transcription
and the maintenance of the transcriptionally silent state
of ISG. We found that the ISG transcription level was in-
creased in TAF-I KD cells compared with control cells in
the transcriptionally silent state and during the early stage
of transcription induced by IFN stimulation. The ISG tran-
scriptionwas aberrantly enhanced by TAF-IKD even in the
absence of IFN, suggesting that TAF-I might have a role
in the silencing mechanism of ISG transcription in the un-
stimulated state. In TAF-I KD cells, the histone H1 level
at the ISG promoter was significantly reduced, whereas the
amounts of the transcriptional complexes and acetylated-
histone H3 on the ISG promoter were increased. In addi-
tion, the histone H1 level at the ISG promoter did not af-
fect the chromatin binding byTAF-I. The ISG transcription
level was enhanced in histone H1 KD cells as well as TAF-I
KD cells comparedwith control cells. TheC-terminal acidic
domain of TAF-I, which is responsible for its histone chap-
erone activity, was required for the repression of ISG tran-
scription. DoubleKD experiments suggested that the target
of TAF-I is histoneH1 in the ISG transcriptional regulation
process. In TAF-I KD and histone H1 KD cells, the chro-
matin structure of the ISG promoter was shown to be more
relaxed compared to that of control cells. Histone H1 plays
a major role in the formation of higher order chromatin
structures (17–19) and affects the binding of the transcrip-
tion factors to DNA, the activity of the ATP-dependent
chromatin remodeling factors and HAT-dependent acety-
lation of histone (44–46,51–54). These results strongly sug-
gest that TAF-I regulates the chromatin structure of ISG
promoters through histone H1 chaperone activity and that
the chromatin binding of histone H1, which is regulated by
TAF-I, inhibits the binding of transcriptional complexes to
the ISG promoter.
TAF-I was associated with the ISG promoter in the tran-
scriptionally silent state and was released after IFN stimu-
lation (Figure 6A), consistent with its role in ISG transcrip-
tional regulation. The amount of acetylated histone on the
ISG promoter was increased in a time-dependent manner
after IFN treatment and correlated well with the increased
transcription factors bounding to the promoter (Figure 3).
This might be due to the recruitment of GCN5 through
STAT2, followed by histone acetylation on the ISG pro-
moter in an IFN-dependent manner (6). The acetylated his-
tone level on the ISG promoter induced by IFN stimulation,
along with the TAF-I dissociation, results in a decrease in
the amount of histone H1 on the ISG promoter (Figures
3B and 6A). This is in good agreement with the previous re-
port that TAF-I binds to unacetylated, hypoacetylated and
repressively modified histones, but not to hyperacetylated
histones (50). These results are consistent with the results
shown in Figure 6B and C, where TSA treatment showed
restrict binding of TAF-I and histone H1 to the ISG pro-
moter.
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Figure 6. Dissociation of TAF-I from ISG promoters. (A) Dynamics of TAF-I at ISG promoters in an IFN-dependent manner. HeLa S3 cells were trans-
fected with TAF-I siRNA expression vector (lanes 1–4) together with empty vector (lane 4) or Flag-tagged TAF-I expression vector (lanes 1–3) and
then treated with or without IFN- for indicated periods. Cells were, then, subjected to ChIP assays using the agarose-conjugated antibody against Flag
followed by qRT-PCR using specific primer sets for each ISG promoter. The amount of DNA co-immunoprecipitated with each antibody was shown as %
of input. Error bars represent standard deviation (n ≥ 3). *P < 0.001 by two-tail-paired Student’s t-test (n = 6). (B) Effects of TSA treatment on binding
of histone H1 to the ISG15 promoter. HeLa S3 cells were treated without (lane 1) or with 0.1 (lane 2) or 1 M (lane 3) of TSA for 1 h and then subjected
to ChIP assays using antibodies specific for histone H3 (H3), acetylated histone H3 (H3K9/14Ac) and histone H1.2 (H1) followed by qRT-PCR using a
specific primer set for the ISG15 promoter. The amount of DNA co-immunoprecipitated with each antibody was shown as % of input. Error bars represent
standard deviation (n ≥ 3). *P < 0.001, **P < 0.0001 by two-tail-paired Student’s t-test (n = 6). The relative amount of H3K9/14Ac for H3 is shown in
H3K9/14Ac/H3 (fourth panel). (C) Effect of TSA treatment on binding of TAF-I to the ISG15 promoter. Cells were prepared as shown in (A) and treated
without (lane 1) or with 0.1 (lane 2) or 1 M (lane 3) of TSA for 1 h and subjected to ChIP assays using the agarose-conjugated antibody against Flag
followed by qRT-PCR using a specific primer set for the ISG15 promoter. The amount of DNA co-immunoprecipitated with each antibody was shown as
% of input. Error bars represent standard deviation (n ≥ 3). *P < 0.01, **P < 0.001 by two-tail-paired Student’s t-test (n = 6).
We propose that TAF-I recruits histone H1 onto the
ISG promoter and hence maintains a relatively close chro-
matin structure at the ISG promoter to prevent aberrant
ISG transcription independent of IFN stimulation. STATs
bring HATs onto the ISG promoter in an IFN-dependent
manner, leading to an increase in the level of acetylated hi-
stone, which in turn causes dissociation of TAF-I from the
ISG promoter. Consequently, the amount of histone H1 on
the ISG promoter is reduced, followed by the formation of
an open chromatin structure that allows optimal binding of
transcriptional complexes and subsequent transcription by
Pol II.
Note that the inhibition of HDAC activity leads to the
global impairment of the ISG transcription, and this may
be due to the impairment of Pol II recruitment onto the
ISG promoter (8–10). These studies imply that the basal
level of histone acetylation on the ISG promoter in the un-
stimulated condition maintains the promoter in the tran-
scriptionally silent state but does so as to enable the rapid
induction of transcription by IFN stimulation. We showed
that histone H1 dynamics are co-ordinated with TAF-I dy-
namics at ISG promoters in an IFN- and a TSA-dependent
manner. Collectively, it is possible that TAF-I may continu-
ously regulate the placement and positioning of histone H1
of certain genes, and it may not only act on gene silencing
maintenance but also in permitting responses to transcrip-
tion inducer.
In this report, we focused on histone H1.2 as a target of
TAF-I in ISG transcriptional regulation, and we observed
significant effects of histone H1.2 KD in each experiment,
implying that at least histone H1.2 plays a role in ISG tran-
scriptional regulation. Indeed, genome-wide studies sug-
gested that there are differential features for histone H1
variants in their distribution on the genome and in the role
for the genes expression (49,55). On the other hand, the ex-
pression levels and the distribution of each histone H1 vari-
ant are strongly dependent on cell types, such as cultured
cell lines, tissues and developmental stages (43,49,55,56).
In addition, TAF-I interacts with not only histone H1.2
but also other histone H1 variants in vivo (29). Therefore,
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we could not exclude the possibility that histone H1 vari-
ants other than H1.2 also have a role in ISG transcription
through the histone H1 chaperone activity of TAF-I.
Recent genome-wide studies suggested that histone H1
is present at proximal and distal gene promoters and is de-
pleted from proximal promoters including TSS in transcrip-
tion activation-dependent manner (55,57–59). Note that hi-
stone H1 depletion was facilitated at proximal promoters
of inducible genes under a stimulating condition (55), and
this is in good agreement with our results. The other im-
portant question is whether the regulatory mechanism by
TAF-I and histone H1 is specific for ISG locus. To address
if TAF-I and histone H1 affect other inducible systems, we
examined the effect of TAF-I and histone H1 KD on the
transcription of IL8 and IκBα, which are dependent onNF-
B (Supplementary Figure S6). In the TAF-I and histone
H1 KD cells, the level of IL8 mRNA was increased in the
TAF-I and histone H1 KD cells in a TNF--unstimulated
condition (Supplementary Figure S6A). The amount of hi-
stone H1 on the IL8 promoter in TAF-I KD cells was re-
duced similar to the ISG promoters (Supplementary Fig-
ure S6B and Figure 3B), suggesting that TAF-I and his-
tone H1 may regulate IL8 transcription through a regula-
tory mechanism similar to that for ISG. In contrast, the
level of IκBα mRNA was not increased in TAF-I nor his-
tone H1 KD. Thus, the regulatory mechanism that depends
on TAF-I and histone H1 is not restricted to ISG tran-
scription but is not a general mechanism that controls all
inducible promoters. There are no consensus sequences in
the proximal promoter regions between the ISG and IL8
genes, so that a specific transcription factor(s), which rec-
ognizes the consensus sequence, may not play a role in the
recruitment of TAF-I on the chromatin. Recent genome-
wide studies have revealed that the promoter/enhancer re-
gions exhibit a characteristic chromatin structure consist-
ing of specific modification, nucleosome positioning and
specific histone variants including histone H1s (1,55,60).
In addition, distal enhancer elements affect gene transcrip-
tion through enhancer–promoter communication by form-
ing chromatin loop structures (41,61,62). The distal en-
hancer elements may also play roles in recruiting negative
regulators, such as TAF-I, to the proximal promoter for the
maintenance of gene silencing.
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